SUTRO BIOPHARMA, INC. – Trademark Portfolio
Entity Type: 03
SUTRO BIOPHARMA, INC. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 10 trademarks are registered and 2 are pending. Notable registered marks include SUTRO, XPRESSCF, XPRESSRS, XTRACTCF, and XPRESSCF+. The owner is based in South San Francisco, CA.
310 Utah Avenue, Suite 150
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
SUTRO BIOPHARMA, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SUTRO BIOPHARMA, INC. have?
SUTRO BIOPHARMA, INC. has 24 U.S. trademarks filed with the USPTO. Of these, 10 registered, 2 pending, 11 abandoned, 1 cancelled.
What trademark classes does SUTRO BIOPHARMA, INC. file in?
SUTRO BIOPHARMA, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SUTRO BIOPHARMA, INC.'s most well-known trademarks?
SUTRO BIOPHARMA, INC.'s registered trademark portfolio includes well-known marks such as SUTRO, XPRESSCF, XPRESSRS, XTRACTCF, and XPRESSCF+. These are among 10 currently registered trademarks in the portfolio.
What is SUTRO BIOPHARMA, INC.'s trademark registration success rate?
SUTRO BIOPHARMA, INC. has a 45% trademark registration rate, with 10 out of 22 resolved applications resulting in successful registration. Currently, 2 applications are pending review.